m
m (Added embedded dosage calculation)
Line 1: Line 1:
{{Infobox drug reference
{{Infobox drug reference
| trade_names =  
| trade_names =  
| drug_class =Neuromuscular blocker  
| drug_class = Neuromuscular blocker
| drug_class_color =neuromuscular_blocker  
| drug_class_color = neuromuscular_blocker
| uses =  
| uses =  
| contraindications =  
| contraindications =  
| routes =IV  
| routes = IV
| dosage =  
| dosage =  
|halflife_redistribution=|protein_binding=|clearance=|halflife_elimination=|adverse_effects=|metabolism=|duration=|time_onset=|mechanism=Nicotinic acetylcholine antagonism|image_file=Cisatracurium.svg}}
| halflife_redistribution =  
| protein_binding =  
| clearance =  
| halflife_elimination =  
| adverse_effects =  
| metabolism =  
| duration =  
| time_onset =  
| dosage_calculation = cisatracurium
| mechanism = Nicotinic acetylcholine antagonism
| image_file = Cisatracurium.svg
}}


Provide a brief summary of this drug here.
Provide a brief summary of this drug here.

Revision as of 00:32, 30 March 2022

Cisatracurium
Cisatracurium.svg
Clinical data
Drug class

Neuromuscular blocker

Routes of administration

IV

Dosage
Adult dosing
Load
  • 0.15-0.2 mg/kg IV (Ideal body weight)
Maintenance (bolus)
  • 0.03 mg/kg IV (Ideal body weight)
Maintenance (infusion)
  • 1-2 mcg/kg/min IV (Ideal body weight)
Indication 
Neuromuscular blockade
Route 
Intravenous
  1. Ingrande J, Lemmens HJ. Dose adjustment of anaesthetics in the morbidly obese. Br J Anaesth. 2010 Dec;105 Suppl 1:i16-23. doi: 10.1093/bja/aeq312. PMID: 21148651.
Pharmacodynamics
Mechanism of action

Nicotinic acetylcholine antagonism

Pharmacokinetics
Physical and chemical data
Article quality
Editor rating
Comprehensive
User likes
0

Provide a brief summary of this drug here.

Uses

Contraindications

Absolute contraindications

Precautions

Pharmacology

Pharmacodynamics

Mechanism of action

Adverse effects

Pharmacokinetics

Chemistry and formulation

History

References